Fundraising Fox
Aaron Royston
InvestorManaging Partner at venBio Partners
San Francisco Bay Area
Writes $20M – $30M checks · typically $25M
Find your path to Aaron
Sign up to see every warm intro you have to Aaron
- Paths you didn't know you had: your email and LinkedIn already hold routes to Aaron. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Aaron Royston, an MD and Wharton MBA with clinical research experience, was recognized as a White House Champion of Change and helped found and guide RayzeBio to IPO and acquisition.
Invests in
BiotechHealthtech
Deals · 6
Marea Therapeutics, Inc.Board seat
via venBio Partners · filed Jun 2024 · $160.4M raise
Rayze BioBoard seat
via venBio Partners · filed Nov 2020 · $45M raise
Harmony BiosciencesBoard seat
via venBio Partners · filed Aug 2019 · $50M raise
Akero Therapeutics, Inc.Board seat
via venBio Partners · filed Dec 2018 · $45.5M raise
Menlo TherapeuticsBoard seat
via venBio Partners · filed Jul 2017 · $50.5M raise
Impel NeuropharmaBoard seat
via venBio Partners · filed Dec 2016 · $37.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
35PharmaAblaze PharmaceuticalsAkeroApellis PharmaceuticalsAttovia TherapeuticsCandid TherapeuticsMarrow TherapeuticsVentyx BiosciencesVentyx BiosciencesVicebio
Investor
Ablaze PharmaceuticalsAkero TherapeuticsAttovia TherapeuticsCeptur TherapeuticsHistoWizImpel PharmaceuticalsINBRACENeurogastrxVentyx BiosciencesVyne Therapeutics
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at venBio Partners
Network4
Investors connected to Aaron in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Aaron Royston?
- Aaron Royston, an MD and Wharton MBA with clinical research experience, was recognized as a White House Champion of Change and helped found and guide RayzeBio to IPO and acquisition.
- Where does Aaron Royston work?
- Aaron Royston is Managing Partner at venBio Partners.
- What does Aaron Royston invest in?
- Aaron Royston invests in Biotech, Healthtech.
- What check size does Aaron Royston write?
- Aaron Royston typically writes checks of $20M – $30M.
- What boards does Aaron Royston sit on?
- Aaron Royston holds tracked board seats at 35Pharma, Ablaze Pharmaceuticals, Akero, Akero Therapeutics, Inc., Apellis Pharmaceuticals, Attovia Therapeutics, Candid Therapeutics, Harmony Biosciences, Harmony Biosciences, Impel Neuropharma.
- What companies has Aaron Royston invested in?
- Investments tracked here include Ablaze Pharmaceuticals, Akero Therapeutics, Attovia Therapeutics, Ceptur Therapeutics, HistoWiz, Impel Pharmaceuticals, INBRACE, Marea Therapeutics, Inc., Neurogastrx, Rayze Bio, Ventyx Biosciences, Vyne Therapeutics.
About this profile. Compiled from public sources — venBio Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights